ResearchVEGF
Genentech Biooncology

Resources for this topic

multimedia callout footer

References

  1. Baselga J. Science. 2006;312:1175-1178.
  2. Goustin AS, Leof EB, Shipley GD, Moses HL. Cancer Res.1986;46:1015-1029.
  3. Busse D, Yakes FM, Lenferink AEG, Arteaga CL. Semin Oncol. 2001;28 (suppl 16):47-55.
  4. Bianco R, Troiani T, Tortora G, Ciardiello F. Endocr Relat Cancer. 2005;12(suppl 1):S159-S171.
  5. Bergers G, Benjamin LE. Nat Rev Cancer. 2003;3:401-410.
  6. O'Dwyer PJ. Oncologist. 2006;11:992-998
  7. Verheul HM, Pinedo HM. Clin Breast Cancer. 2000;1(suppl 1): S80-S84.
  8. Ranieri G, Gasparini G. Curr Drug Targets Immune Endocr Metabol Disord. 2001;1:241-253.
  9. Mukhopadhyay D, Datta K. Semin Cancer Biol. 2004;14:123-130.
  10. Gerber HP, Ferrara N. Cancer Res. 2005;65:671-680.
  11. Folkman J. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. Vol 2. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:2865-2882.
  12. Jain RK, Duda DG, Clark JW, Loeffler JS. Nat Clin Pract Oncol. 2006;3:24-40.
  13. Bergers G, Brekken R, McMahon G, et al. Nat Cell Biol. 2000;2:737-744.
  14. Inoue M, Hager JH, Ferrara N, et al. Cancer Cell. 2002;1:193-202.
  15. Mancuso MR, Davis R, Norberg SM, et al. J Clin Invest. 2006;116:2610-2621.
  16. Vosseler S, Mirancea N, Bohlen P, et al. Cancer Res. 2005;65:1294-1305.
  17. Baluk P, Hashizume H, McDonald DM. Curr Opin Genet Dev. 2005;15:102-111.
  18. Inai T, Mancuso M, Hashizume H, et al. Am J Pathol. 2004;165:35-52.
  19. Hurwitz H, Fehrenbacher L, Novotny W, et al. N Engl J Med. 2004;350:2335-2342.
  20. Sandler A, Gray R, Perry MC, et al. N Engl J Med. 2006;355:2542-2550.
  21. Motzer RJ, Michaelson MD, Redman BG, et al. J Clin Oncol. 2006;24:16-24.
  22. Ratain MJ, Eisen T, Stader WM, et al. J Clin Oncol. 2006;24:2505-2512.
  23. Rugo HS, Herbst RS, Liu G, et al. J Clin Oncol. 2005;23:5474-5483.
  24. Herbst RS. Expert Opin Emerging Drugs. 2006;11:635-650.
  25. Sweeney CJ, Miller KD, Sledge GW. Trends Mol Med. 2003;9:24-29.
  26. Ton NC, Jayson GC. Curr Pharm Des. 2004;10:51-64.
  27. Kerbel RS, Yu J, Tran J, et al. Cancer Metastasis Rev. 2001;20:79-86.
  28. Hicklin DJ, Ellis LM. J Clin Oncol. 2005;23:1011-1027.
  29. Herbst RS. Expert Opin Emerging Drugs. 2006;11:635-650.
Next section

The role of VEGF across tumor types